Drugs & Targets Reblozyl approved by European Commission for transfusion-dependent anemia in adults with MDS or beta thalassemia July 02, 2020Vol.46 No.27
Drugs & Targets Guardant Health launches real-world clinical-genomic platform to accelerate precision oncology drug development July 02, 2020Vol.46 No.27
Drugs & TargetsFree FDA approves Keytruda for cutaneous squamous cell carcinoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Selinexor receives FDA approval for relapsed/refractory diffuse large B-cell lymphoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Keytruda approved in China for second-line treatment of locally advanced or metastatic ESCC indication June 26, 2020Vol.46 No.26
Drugs & TargetsFree Keytruda receives second biomarker-based indication from FDA, regardless of tumor type June 19, 2020Vol.46 No.25
Drugs & TargetsFree FoundationOne CDx receives FDA approval as companion diagnostic with Keytruda June 19, 2020Vol.46 No.25
Drugs & TargetsFree Lurbinectedin receives accelerated approval by FDA for metastatic SCLC June 19, 2020Vol.46 No.25
Drugs & TargetsFree Gemtuzumab ozogamicin receives extended indication for CD33-positive AML in pediatric patients June 19, 2020Vol.46 No.25
